Medical Care
Global Molecular Diagnostics Infectious Disease Testing Market Research Report 2024
- Aug 28, 24
- ID: 515380
- Pages: 84
- Figures: 160
- Views: 3
Molecular diagnostics is a technique used to detect the presence of and identify genetic materials and proteins associated with specific health conditions and diseases, and infectious agents in body fluids such as blood, urine, or sputum. Molecular diagnostics for infectious disease testing is used by hospitals, academics institutions, laboratories, and others.
The global Molecular Diagnostics Infectious Disease Testing market was valued at US$ million in 2023 and is anticipated to reach US$ million by 2030, witnessing a CAGR of % during the forecast period 2024-2030.
The global pharmaceutical market is 1475 billion USD in 2022, growing at a CAGR of 5% during the next six years. The pharmaceutical market includes chemical drugs and biological drugs. For biologics is expected to 381 billion USD in 2022. In comparison, the chemical drug market is estimated to increase from 1005 billion in 2018 to 1094 billion U.S. dollars in 2022. The pharmaceutical market factors such as increasing demand for healthcare, technological advancements, and the rising prevalence of chronic diseases, increase in funding from private & government organizations for development of pharmaceutical manufacturing segments and rise in R&D activities for drugs. However, the industry also faces challenges such as stringent regulations, high costs of research and development, and patent expirations. Companies need to continuously innovate and adapt to these challenges to stay competitive in the market and ensure their products reach patients in need. Additionally, the COVID-19 pandemic has highlighted the importance of vaccine development and supply chain management, further emphasizing the need for pharmaceutical companies to be agile and responsive to emerging public health needs.
This report aims to provide a comprehensive presentation of the global market for Molecular Diagnostics Infectious Disease Testing, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Molecular Diagnostics Infectious Disease Testing.
Report Scope
The Molecular Diagnostics Infectious Disease Testing market size, estimations, and forecasts are provided in terms of revenue ($ millions), considering 2023 as the base year, with history and forecast data for the period from 2019 to 2030. This report segments the global Molecular Diagnostics Infectious Disease Testing market comprehensively. Regional market sizes, concerning products by Type, by Application, and by players, are also provided.
For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.
The report will help the Molecular Diagnostics Infectious Disease Testing companies, new entrants, and industry chain related companies in this market with information on the revenues, sales volume, and average price for the overall market and the sub-segments across the different segments, by company, by Type, by Application, and by regions.
Market Segmentation
By Company
Abbott Laboratories
BD
bioMérieux
Thermo Fisher Scientific
F. Hoffmann-La Roche
Siemens AG
Veridex
Luminex
GenMark Diagnostics
Qiagen NV
Genomix Biotech
BioTheranostics
GenMark Diagnostics
Segment by Type
Bacterial Infectious Disease Testing
Viral Infectious Disease Testing
Parasitic Infectious Disease Testing
Segment by Application
Hospital
Laboratory Research
By Region
North America
United States
Canada
Europe
Germany
France
UK
Italy
Russia
Nordic Countries
Rest of Europe
Asia-Pacific
China
Japan
South Korea
Southeast Asia
India
Australia
Rest of Asia
Latin America
Mexico
Brazil
Rest of Latin America
Middle East & Africa
Turkey
Saudi Arabia
UAE
Rest of MEA
Chapter Outline
Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by Type, by Application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2: Introduces executive summary of global market size, regional market size, this section also introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by companies in the industry, and the analysis of relevant policies in the industry.
Chapter 3: Detailed analysis of Molecular Diagnostics Infectious Disease Testing companies’ competitive landscape, revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 4: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6, 7, 8, 9, 10: North America, Europe, Asia Pacific, Latin America, Middle East and Africa segment by country. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world.
Chapter 11: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 12: The main points and conclusions of the report.
The global Molecular Diagnostics Infectious Disease Testing market was valued at US$ million in 2023 and is anticipated to reach US$ million by 2030, witnessing a CAGR of % during the forecast period 2024-2030.
The global pharmaceutical market is 1475 billion USD in 2022, growing at a CAGR of 5% during the next six years. The pharmaceutical market includes chemical drugs and biological drugs. For biologics is expected to 381 billion USD in 2022. In comparison, the chemical drug market is estimated to increase from 1005 billion in 2018 to 1094 billion U.S. dollars in 2022. The pharmaceutical market factors such as increasing demand for healthcare, technological advancements, and the rising prevalence of chronic diseases, increase in funding from private & government organizations for development of pharmaceutical manufacturing segments and rise in R&D activities for drugs. However, the industry also faces challenges such as stringent regulations, high costs of research and development, and patent expirations. Companies need to continuously innovate and adapt to these challenges to stay competitive in the market and ensure their products reach patients in need. Additionally, the COVID-19 pandemic has highlighted the importance of vaccine development and supply chain management, further emphasizing the need for pharmaceutical companies to be agile and responsive to emerging public health needs.
This report aims to provide a comprehensive presentation of the global market for Molecular Diagnostics Infectious Disease Testing, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Molecular Diagnostics Infectious Disease Testing.
Report Scope
The Molecular Diagnostics Infectious Disease Testing market size, estimations, and forecasts are provided in terms of revenue ($ millions), considering 2023 as the base year, with history and forecast data for the period from 2019 to 2030. This report segments the global Molecular Diagnostics Infectious Disease Testing market comprehensively. Regional market sizes, concerning products by Type, by Application, and by players, are also provided.
For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.
The report will help the Molecular Diagnostics Infectious Disease Testing companies, new entrants, and industry chain related companies in this market with information on the revenues, sales volume, and average price for the overall market and the sub-segments across the different segments, by company, by Type, by Application, and by regions.
Market Segmentation
By Company
Abbott Laboratories
BD
bioMérieux
Thermo Fisher Scientific
F. Hoffmann-La Roche
Siemens AG
Veridex
Luminex
GenMark Diagnostics
Qiagen NV
Genomix Biotech
BioTheranostics
GenMark Diagnostics
Segment by Type
Bacterial Infectious Disease Testing
Viral Infectious Disease Testing
Parasitic Infectious Disease Testing
Segment by Application
Hospital
Laboratory Research
By Region
North America
United States
Canada
Europe
Germany
France
UK
Italy
Russia
Nordic Countries
Rest of Europe
Asia-Pacific
China
Japan
South Korea
Southeast Asia
India
Australia
Rest of Asia
Latin America
Mexico
Brazil
Rest of Latin America
Middle East & Africa
Turkey
Saudi Arabia
UAE
Rest of MEA
Chapter Outline
Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by Type, by Application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2: Introduces executive summary of global market size, regional market size, this section also introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by companies in the industry, and the analysis of relevant policies in the industry.
Chapter 3: Detailed analysis of Molecular Diagnostics Infectious Disease Testing companies’ competitive landscape, revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 4: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6, 7, 8, 9, 10: North America, Europe, Asia Pacific, Latin America, Middle East and Africa segment by country. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world.
Chapter 11: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 12: The main points and conclusions of the report.
1 Report Overview
1.1 Study Scope
1.2 Market Analysis by Type
1.2.1 Global Molecular Diagnostics Infectious Disease Testing Market Size Growth Rate by Type: 2019 VS 2023 VS 2030
1.2.2 Bacterial Infectious Disease Testing
1.2.3 Viral Infectious Disease Testing
1.2.4 Parasitic Infectious Disease Testing
1.3 Market by Application
1.3.1 Global Molecular Diagnostics Infectious Disease Testing Market Growth by Application: 2019 VS 2023 VS 2030
1.3.2 Hospital
1.3.3 Laboratory Research
1.4 Study Objectives
1.5 Years Considered
1.6 Years Considered
2 Global Growth Trends
2.1 Global Molecular Diagnostics Infectious Disease Testing Market Perspective (2019-2030)
2.2 Molecular Diagnostics Infectious Disease Testing Growth Trends by Region
2.2.1 Global Molecular Diagnostics Infectious Disease Testing Market Size by Region: 2019 VS 2023 VS 2030
2.2.2 Molecular Diagnostics Infectious Disease Testing Historic Market Size by Region (2019-2024)
2.2.3 Molecular Diagnostics Infectious Disease Testing Forecasted Market Size by Region (2025-2030)
2.3 Molecular Diagnostics Infectious Disease Testing Market Dynamics
2.3.1 Molecular Diagnostics Infectious Disease Testing Industry Trends
2.3.2 Molecular Diagnostics Infectious Disease Testing Market Drivers
2.3.3 Molecular Diagnostics Infectious Disease Testing Market Challenges
2.3.4 Molecular Diagnostics Infectious Disease Testing Market Restraints
3 Competition Landscape by Key Players
3.1 Global Top Molecular Diagnostics Infectious Disease Testing Players by Revenue
3.1.1 Global Top Molecular Diagnostics Infectious Disease Testing Players by Revenue (2019-2024)
3.1.2 Global Molecular Diagnostics Infectious Disease Testing Revenue Market Share by Players (2019-2024)
3.2 Global Molecular Diagnostics Infectious Disease Testing Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
3.3 Players Covered: Ranking by Molecular Diagnostics Infectious Disease Testing Revenue
3.4 Global Molecular Diagnostics Infectious Disease Testing Market Concentration Ratio
3.4.1 Global Molecular Diagnostics Infectious Disease Testing Market Concentration Ratio (CR5 and HHI)
3.4.2 Global Top 10 and Top 5 Companies by Molecular Diagnostics Infectious Disease Testing Revenue in 2023
3.5 Molecular Diagnostics Infectious Disease Testing Key Players Head office and Area Served
3.6 Key Players Molecular Diagnostics Infectious Disease Testing Product Solution and Service
3.7 Date of Enter into Molecular Diagnostics Infectious Disease Testing Market
3.8 Mergers & Acquisitions, Expansion Plans
4 Molecular Diagnostics Infectious Disease Testing Breakdown Data by Type
4.1 Global Molecular Diagnostics Infectious Disease Testing Historic Market Size by Type (2019-2024)
4.2 Global Molecular Diagnostics Infectious Disease Testing Forecasted Market Size by Type (2025-2030)
5 Molecular Diagnostics Infectious Disease Testing Breakdown Data by Application
5.1 Global Molecular Diagnostics Infectious Disease Testing Historic Market Size by Application (2019-2024)
5.2 Global Molecular Diagnostics Infectious Disease Testing Forecasted Market Size by Application (2025-2030)
6 North America
6.1 North America Molecular Diagnostics Infectious Disease Testing Market Size (2019-2030)
6.2 North America Molecular Diagnostics Infectious Disease Testing Market Growth Rate by Country: 2019 VS 2023 VS 2030
6.3 North America Molecular Diagnostics Infectious Disease Testing Market Size by Country (2019-2024)
6.4 North America Molecular Diagnostics Infectious Disease Testing Market Size by Country (2025-2030)
6.5 United States
6.6 Canada
7 Europe
7.1 Europe Molecular Diagnostics Infectious Disease Testing Market Size (2019-2030)
7.2 Europe Molecular Diagnostics Infectious Disease Testing Market Growth Rate by Country: 2019 VS 2023 VS 2030
7.3 Europe Molecular Diagnostics Infectious Disease Testing Market Size by Country (2019-2024)
7.4 Europe Molecular Diagnostics Infectious Disease Testing Market Size by Country (2025-2030)
7.5 Germany
7.6 France
7.7 U.K.
7.8 Italy
7.9 Russia
7.10 Nordic Countries
8 Asia-Pacific
8.1 Asia-Pacific Molecular Diagnostics Infectious Disease Testing Market Size (2019-2030)
8.2 Asia-Pacific Molecular Diagnostics Infectious Disease Testing Market Growth Rate by Region: 2019 VS 2023 VS 2030
8.3 Asia-Pacific Molecular Diagnostics Infectious Disease Testing Market Size by Region (2019-2024)
8.4 Asia-Pacific Molecular Diagnostics Infectious Disease Testing Market Size by Region (2025-2030)
8.5 China
8.6 Japan
8.7 South Korea
8.8 Southeast Asia
8.9 India
8.10 Australia
9 Latin America
9.1 Latin America Molecular Diagnostics Infectious Disease Testing Market Size (2019-2030)
9.2 Latin America Molecular Diagnostics Infectious Disease Testing Market Growth Rate by Country: 2019 VS 2023 VS 2030
9.3 Latin America Molecular Diagnostics Infectious Disease Testing Market Size by Country (2019-2024)
9.4 Latin America Molecular Diagnostics Infectious Disease Testing Market Size by Country (2025-2030)
9.5 Mexico
9.6 Brazil
10 Middle East & Africa
10.1 Middle East & Africa Molecular Diagnostics Infectious Disease Testing Market Size (2019-2030)
10.2 Middle East & Africa Molecular Diagnostics Infectious Disease Testing Market Growth Rate by Country: 2019 VS 2023 VS 2030
10.3 Middle East & Africa Molecular Diagnostics Infectious Disease Testing Market Size by Country (2019-2024)
10.4 Middle East & Africa Molecular Diagnostics Infectious Disease Testing Market Size by Country (2025-2030)
10.5 Turkey
10.6 Saudi Arabia
10.7 UAE
11 Key Players Profiles
11.1 Abbott Laboratories
11.1.1 Abbott Laboratories Company Detail
11.1.2 Abbott Laboratories Business Overview
11.1.3 Abbott Laboratories Molecular Diagnostics Infectious Disease Testing Introduction
11.1.4 Abbott Laboratories Revenue in Molecular Diagnostics Infectious Disease Testing Business (2019-2024)
11.1.5 Abbott Laboratories Recent Development
11.2 BD
11.2.1 BD Company Detail
11.2.2 BD Business Overview
11.2.3 BD Molecular Diagnostics Infectious Disease Testing Introduction
11.2.4 BD Revenue in Molecular Diagnostics Infectious Disease Testing Business (2019-2024)
11.2.5 BD Recent Development
11.3 bioMérieux
11.3.1 bioMérieux Company Detail
11.3.2 bioMérieux Business Overview
11.3.3 bioMérieux Molecular Diagnostics Infectious Disease Testing Introduction
11.3.4 bioMérieux Revenue in Molecular Diagnostics Infectious Disease Testing Business (2019-2024)
11.3.5 bioMérieux Recent Development
11.4 Thermo Fisher Scientific
11.4.1 Thermo Fisher Scientific Company Detail
11.4.2 Thermo Fisher Scientific Business Overview
11.4.3 Thermo Fisher Scientific Molecular Diagnostics Infectious Disease Testing Introduction
11.4.4 Thermo Fisher Scientific Revenue in Molecular Diagnostics Infectious Disease Testing Business (2019-2024)
11.4.5 Thermo Fisher Scientific Recent Development
11.5 F. Hoffmann-La Roche
11.5.1 F. Hoffmann-La Roche Company Detail
11.5.2 F. Hoffmann-La Roche Business Overview
11.5.3 F. Hoffmann-La Roche Molecular Diagnostics Infectious Disease Testing Introduction
11.5.4 F. Hoffmann-La Roche Revenue in Molecular Diagnostics Infectious Disease Testing Business (2019-2024)
11.5.5 F. Hoffmann-La Roche Recent Development
11.6 Siemens AG
11.6.1 Siemens AG Company Detail
11.6.2 Siemens AG Business Overview
11.6.3 Siemens AG Molecular Diagnostics Infectious Disease Testing Introduction
11.6.4 Siemens AG Revenue in Molecular Diagnostics Infectious Disease Testing Business (2019-2024)
11.6.5 Siemens AG Recent Development
11.7 Veridex
11.7.1 Veridex Company Detail
11.7.2 Veridex Business Overview
11.7.3 Veridex Molecular Diagnostics Infectious Disease Testing Introduction
11.7.4 Veridex Revenue in Molecular Diagnostics Infectious Disease Testing Business (2019-2024)
11.7.5 Veridex Recent Development
11.8 Luminex
11.8.1 Luminex Company Detail
11.8.2 Luminex Business Overview
11.8.3 Luminex Molecular Diagnostics Infectious Disease Testing Introduction
11.8.4 Luminex Revenue in Molecular Diagnostics Infectious Disease Testing Business (2019-2024)
11.8.5 Luminex Recent Development
11.9 GenMark Diagnostics
11.9.1 GenMark Diagnostics Company Detail
11.9.2 GenMark Diagnostics Business Overview
11.9.3 GenMark Diagnostics Molecular Diagnostics Infectious Disease Testing Introduction
11.9.4 GenMark Diagnostics Revenue in Molecular Diagnostics Infectious Disease Testing Business (2019-2024)
11.9.5 GenMark Diagnostics Recent Development
11.10 Qiagen NV
11.10.1 Qiagen NV Company Detail
11.10.2 Qiagen NV Business Overview
11.10.3 Qiagen NV Molecular Diagnostics Infectious Disease Testing Introduction
11.10.4 Qiagen NV Revenue in Molecular Diagnostics Infectious Disease Testing Business (2019-2024)
11.10.5 Qiagen NV Recent Development
11.11 Genomix Biotech
11.11.1 Genomix Biotech Company Detail
11.11.2 Genomix Biotech Business Overview
11.11.3 Genomix Biotech Molecular Diagnostics Infectious Disease Testing Introduction
11.11.4 Genomix Biotech Revenue in Molecular Diagnostics Infectious Disease Testing Business (2019-2024)
11.11.5 Genomix Biotech Recent Development
11.12 BioTheranostics
11.12.1 BioTheranostics Company Detail
11.12.2 BioTheranostics Business Overview
11.12.3 BioTheranostics Molecular Diagnostics Infectious Disease Testing Introduction
11.12.4 BioTheranostics Revenue in Molecular Diagnostics Infectious Disease Testing Business (2019-2024)
11.12.5 BioTheranostics Recent Development
11.13 GenMark Diagnostics
11.13.1 GenMark Diagnostics Company Detail
11.13.2 GenMark Diagnostics Business Overview
11.13.3 GenMark Diagnostics Molecular Diagnostics Infectious Disease Testing Introduction
11.13.4 GenMark Diagnostics Revenue in Molecular Diagnostics Infectious Disease Testing Business (2019-2024)
11.13.5 GenMark Diagnostics Recent Development
12 Analyst's Viewpoints/Conclusions
13 Appendix
13.1 Research Methodology
13.1.1 Methodology/Research Approach
13.1.2 Data Source
13.2 Disclaimer
13.3 Author Details
1.1 Study Scope
1.2 Market Analysis by Type
1.2.1 Global Molecular Diagnostics Infectious Disease Testing Market Size Growth Rate by Type: 2019 VS 2023 VS 2030
1.2.2 Bacterial Infectious Disease Testing
1.2.3 Viral Infectious Disease Testing
1.2.4 Parasitic Infectious Disease Testing
1.3 Market by Application
1.3.1 Global Molecular Diagnostics Infectious Disease Testing Market Growth by Application: 2019 VS 2023 VS 2030
1.3.2 Hospital
1.3.3 Laboratory Research
1.4 Study Objectives
1.5 Years Considered
1.6 Years Considered
2 Global Growth Trends
2.1 Global Molecular Diagnostics Infectious Disease Testing Market Perspective (2019-2030)
2.2 Molecular Diagnostics Infectious Disease Testing Growth Trends by Region
2.2.1 Global Molecular Diagnostics Infectious Disease Testing Market Size by Region: 2019 VS 2023 VS 2030
2.2.2 Molecular Diagnostics Infectious Disease Testing Historic Market Size by Region (2019-2024)
2.2.3 Molecular Diagnostics Infectious Disease Testing Forecasted Market Size by Region (2025-2030)
2.3 Molecular Diagnostics Infectious Disease Testing Market Dynamics
2.3.1 Molecular Diagnostics Infectious Disease Testing Industry Trends
2.3.2 Molecular Diagnostics Infectious Disease Testing Market Drivers
2.3.3 Molecular Diagnostics Infectious Disease Testing Market Challenges
2.3.4 Molecular Diagnostics Infectious Disease Testing Market Restraints
3 Competition Landscape by Key Players
3.1 Global Top Molecular Diagnostics Infectious Disease Testing Players by Revenue
3.1.1 Global Top Molecular Diagnostics Infectious Disease Testing Players by Revenue (2019-2024)
3.1.2 Global Molecular Diagnostics Infectious Disease Testing Revenue Market Share by Players (2019-2024)
3.2 Global Molecular Diagnostics Infectious Disease Testing Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
3.3 Players Covered: Ranking by Molecular Diagnostics Infectious Disease Testing Revenue
3.4 Global Molecular Diagnostics Infectious Disease Testing Market Concentration Ratio
3.4.1 Global Molecular Diagnostics Infectious Disease Testing Market Concentration Ratio (CR5 and HHI)
3.4.2 Global Top 10 and Top 5 Companies by Molecular Diagnostics Infectious Disease Testing Revenue in 2023
3.5 Molecular Diagnostics Infectious Disease Testing Key Players Head office and Area Served
3.6 Key Players Molecular Diagnostics Infectious Disease Testing Product Solution and Service
3.7 Date of Enter into Molecular Diagnostics Infectious Disease Testing Market
3.8 Mergers & Acquisitions, Expansion Plans
4 Molecular Diagnostics Infectious Disease Testing Breakdown Data by Type
4.1 Global Molecular Diagnostics Infectious Disease Testing Historic Market Size by Type (2019-2024)
4.2 Global Molecular Diagnostics Infectious Disease Testing Forecasted Market Size by Type (2025-2030)
5 Molecular Diagnostics Infectious Disease Testing Breakdown Data by Application
5.1 Global Molecular Diagnostics Infectious Disease Testing Historic Market Size by Application (2019-2024)
5.2 Global Molecular Diagnostics Infectious Disease Testing Forecasted Market Size by Application (2025-2030)
6 North America
6.1 North America Molecular Diagnostics Infectious Disease Testing Market Size (2019-2030)
6.2 North America Molecular Diagnostics Infectious Disease Testing Market Growth Rate by Country: 2019 VS 2023 VS 2030
6.3 North America Molecular Diagnostics Infectious Disease Testing Market Size by Country (2019-2024)
6.4 North America Molecular Diagnostics Infectious Disease Testing Market Size by Country (2025-2030)
6.5 United States
6.6 Canada
7 Europe
7.1 Europe Molecular Diagnostics Infectious Disease Testing Market Size (2019-2030)
7.2 Europe Molecular Diagnostics Infectious Disease Testing Market Growth Rate by Country: 2019 VS 2023 VS 2030
7.3 Europe Molecular Diagnostics Infectious Disease Testing Market Size by Country (2019-2024)
7.4 Europe Molecular Diagnostics Infectious Disease Testing Market Size by Country (2025-2030)
7.5 Germany
7.6 France
7.7 U.K.
7.8 Italy
7.9 Russia
7.10 Nordic Countries
8 Asia-Pacific
8.1 Asia-Pacific Molecular Diagnostics Infectious Disease Testing Market Size (2019-2030)
8.2 Asia-Pacific Molecular Diagnostics Infectious Disease Testing Market Growth Rate by Region: 2019 VS 2023 VS 2030
8.3 Asia-Pacific Molecular Diagnostics Infectious Disease Testing Market Size by Region (2019-2024)
8.4 Asia-Pacific Molecular Diagnostics Infectious Disease Testing Market Size by Region (2025-2030)
8.5 China
8.6 Japan
8.7 South Korea
8.8 Southeast Asia
8.9 India
8.10 Australia
9 Latin America
9.1 Latin America Molecular Diagnostics Infectious Disease Testing Market Size (2019-2030)
9.2 Latin America Molecular Diagnostics Infectious Disease Testing Market Growth Rate by Country: 2019 VS 2023 VS 2030
9.3 Latin America Molecular Diagnostics Infectious Disease Testing Market Size by Country (2019-2024)
9.4 Latin America Molecular Diagnostics Infectious Disease Testing Market Size by Country (2025-2030)
9.5 Mexico
9.6 Brazil
10 Middle East & Africa
10.1 Middle East & Africa Molecular Diagnostics Infectious Disease Testing Market Size (2019-2030)
10.2 Middle East & Africa Molecular Diagnostics Infectious Disease Testing Market Growth Rate by Country: 2019 VS 2023 VS 2030
10.3 Middle East & Africa Molecular Diagnostics Infectious Disease Testing Market Size by Country (2019-2024)
10.4 Middle East & Africa Molecular Diagnostics Infectious Disease Testing Market Size by Country (2025-2030)
10.5 Turkey
10.6 Saudi Arabia
10.7 UAE
11 Key Players Profiles
11.1 Abbott Laboratories
11.1.1 Abbott Laboratories Company Detail
11.1.2 Abbott Laboratories Business Overview
11.1.3 Abbott Laboratories Molecular Diagnostics Infectious Disease Testing Introduction
11.1.4 Abbott Laboratories Revenue in Molecular Diagnostics Infectious Disease Testing Business (2019-2024)
11.1.5 Abbott Laboratories Recent Development
11.2 BD
11.2.1 BD Company Detail
11.2.2 BD Business Overview
11.2.3 BD Molecular Diagnostics Infectious Disease Testing Introduction
11.2.4 BD Revenue in Molecular Diagnostics Infectious Disease Testing Business (2019-2024)
11.2.5 BD Recent Development
11.3 bioMérieux
11.3.1 bioMérieux Company Detail
11.3.2 bioMérieux Business Overview
11.3.3 bioMérieux Molecular Diagnostics Infectious Disease Testing Introduction
11.3.4 bioMérieux Revenue in Molecular Diagnostics Infectious Disease Testing Business (2019-2024)
11.3.5 bioMérieux Recent Development
11.4 Thermo Fisher Scientific
11.4.1 Thermo Fisher Scientific Company Detail
11.4.2 Thermo Fisher Scientific Business Overview
11.4.3 Thermo Fisher Scientific Molecular Diagnostics Infectious Disease Testing Introduction
11.4.4 Thermo Fisher Scientific Revenue in Molecular Diagnostics Infectious Disease Testing Business (2019-2024)
11.4.5 Thermo Fisher Scientific Recent Development
11.5 F. Hoffmann-La Roche
11.5.1 F. Hoffmann-La Roche Company Detail
11.5.2 F. Hoffmann-La Roche Business Overview
11.5.3 F. Hoffmann-La Roche Molecular Diagnostics Infectious Disease Testing Introduction
11.5.4 F. Hoffmann-La Roche Revenue in Molecular Diagnostics Infectious Disease Testing Business (2019-2024)
11.5.5 F. Hoffmann-La Roche Recent Development
11.6 Siemens AG
11.6.1 Siemens AG Company Detail
11.6.2 Siemens AG Business Overview
11.6.3 Siemens AG Molecular Diagnostics Infectious Disease Testing Introduction
11.6.4 Siemens AG Revenue in Molecular Diagnostics Infectious Disease Testing Business (2019-2024)
11.6.5 Siemens AG Recent Development
11.7 Veridex
11.7.1 Veridex Company Detail
11.7.2 Veridex Business Overview
11.7.3 Veridex Molecular Diagnostics Infectious Disease Testing Introduction
11.7.4 Veridex Revenue in Molecular Diagnostics Infectious Disease Testing Business (2019-2024)
11.7.5 Veridex Recent Development
11.8 Luminex
11.8.1 Luminex Company Detail
11.8.2 Luminex Business Overview
11.8.3 Luminex Molecular Diagnostics Infectious Disease Testing Introduction
11.8.4 Luminex Revenue in Molecular Diagnostics Infectious Disease Testing Business (2019-2024)
11.8.5 Luminex Recent Development
11.9 GenMark Diagnostics
11.9.1 GenMark Diagnostics Company Detail
11.9.2 GenMark Diagnostics Business Overview
11.9.3 GenMark Diagnostics Molecular Diagnostics Infectious Disease Testing Introduction
11.9.4 GenMark Diagnostics Revenue in Molecular Diagnostics Infectious Disease Testing Business (2019-2024)
11.9.5 GenMark Diagnostics Recent Development
11.10 Qiagen NV
11.10.1 Qiagen NV Company Detail
11.10.2 Qiagen NV Business Overview
11.10.3 Qiagen NV Molecular Diagnostics Infectious Disease Testing Introduction
11.10.4 Qiagen NV Revenue in Molecular Diagnostics Infectious Disease Testing Business (2019-2024)
11.10.5 Qiagen NV Recent Development
11.11 Genomix Biotech
11.11.1 Genomix Biotech Company Detail
11.11.2 Genomix Biotech Business Overview
11.11.3 Genomix Biotech Molecular Diagnostics Infectious Disease Testing Introduction
11.11.4 Genomix Biotech Revenue in Molecular Diagnostics Infectious Disease Testing Business (2019-2024)
11.11.5 Genomix Biotech Recent Development
11.12 BioTheranostics
11.12.1 BioTheranostics Company Detail
11.12.2 BioTheranostics Business Overview
11.12.3 BioTheranostics Molecular Diagnostics Infectious Disease Testing Introduction
11.12.4 BioTheranostics Revenue in Molecular Diagnostics Infectious Disease Testing Business (2019-2024)
11.12.5 BioTheranostics Recent Development
11.13 GenMark Diagnostics
11.13.1 GenMark Diagnostics Company Detail
11.13.2 GenMark Diagnostics Business Overview
11.13.3 GenMark Diagnostics Molecular Diagnostics Infectious Disease Testing Introduction
11.13.4 GenMark Diagnostics Revenue in Molecular Diagnostics Infectious Disease Testing Business (2019-2024)
11.13.5 GenMark Diagnostics Recent Development
12 Analyst's Viewpoints/Conclusions
13 Appendix
13.1 Research Methodology
13.1.1 Methodology/Research Approach
13.1.2 Data Source
13.2 Disclaimer
13.3 Author Details
List of Tables
Table 1. Global Molecular Diagnostics Infectious Disease Testing Market Size Growth Rate by Type (US$ Million): 2019 VS 2023 VS 2030
Table 2. Key Players of Bacterial Infectious Disease Testing
Table 3. Key Players of Viral Infectious Disease Testing
Table 4. Key Players of Parasitic Infectious Disease Testing
Table 5. Global Molecular Diagnostics Infectious Disease Testing Market Size Growth by Application (US$ Million): 2019 VS 2023 VS 2030
Table 6. Global Molecular Diagnostics Infectious Disease Testing Market Size by Region (US$ Million): 2019 VS 2023 VS 2030
Table 7. Global Molecular Diagnostics Infectious Disease Testing Market Size by Region (2019-2024) & (US$ Million)
Table 8. Global Molecular Diagnostics Infectious Disease Testing Market Share by Region (2019-2024)
Table 9. Global Molecular Diagnostics Infectious Disease Testing Forecasted Market Size by Region (2025-2030) & (US$ Million)
Table 10. Global Molecular Diagnostics Infectious Disease Testing Market Share by Region (2025-2030)
Table 11. Molecular Diagnostics Infectious Disease Testing Market Trends
Table 12. Molecular Diagnostics Infectious Disease Testing Market Drivers
Table 13. Molecular Diagnostics Infectious Disease Testing Market Challenges
Table 14. Molecular Diagnostics Infectious Disease Testing Market Restraints
Table 15. Global Molecular Diagnostics Infectious Disease Testing Revenue by Players (2019-2024) & (US$ Million)
Table 16. Global Molecular Diagnostics Infectious Disease Testing Market Share by Players (2019-2024)
Table 17. Global Top Molecular Diagnostics Infectious Disease Testing Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Molecular Diagnostics Infectious Disease Testing as of 2023)
Table 18. Ranking of Global Top Molecular Diagnostics Infectious Disease Testing Companies by Revenue (US$ Million) in 2023
Table 19. Global 5 Largest Players Market Share by Molecular Diagnostics Infectious Disease Testing Revenue (CR5 and HHI) & (2019-2024)
Table 20. Key Players Headquarters and Area Served
Table 21. Key Players Molecular Diagnostics Infectious Disease Testing Product Solution and Service
Table 22. Date of Enter into Molecular Diagnostics Infectious Disease Testing Market
Table 23. Mergers & Acquisitions, Expansion Plans
Table 24. Global Molecular Diagnostics Infectious Disease Testing Market Size by Type (2019-2024) & (US$ Million)
Table 25. Global Molecular Diagnostics Infectious Disease Testing Revenue Market Share by Type (2019-2024)
Table 26. Global Molecular Diagnostics Infectious Disease Testing Forecasted Market Size by Type (2025-2030) & (US$ Million)
Table 27. Global Molecular Diagnostics Infectious Disease Testing Revenue Market Share by Type (2025-2030)
Table 28. Global Molecular Diagnostics Infectious Disease Testing Market Size by Application (2019-2024) & (US$ Million)
Table 29. Global Molecular Diagnostics Infectious Disease Testing Revenue Market Share by Application (2019-2024)
Table 30. Global Molecular Diagnostics Infectious Disease Testing Forecasted Market Size by Application (2025-2030) & (US$ Million)
Table 31. Global Molecular Diagnostics Infectious Disease Testing Revenue Market Share by Application (2025-2030)
Table 32. North America Molecular Diagnostics Infectious Disease Testing Market Size Growth Rate by Country (US$ Million): 2019 VS 2023 VS 2030
Table 33. North America Molecular Diagnostics Infectious Disease Testing Market Size by Country (2019-2024) & (US$ Million)
Table 34. North America Molecular Diagnostics Infectious Disease Testing Market Size by Country (2025-2030) & (US$ Million)
Table 35. Europe Molecular Diagnostics Infectious Disease Testing Market Size Growth Rate by Country (US$ Million): 2019 VS 2023 VS 2030
Table 36. Europe Molecular Diagnostics Infectious Disease Testing Market Size by Country (2019-2024) & (US$ Million)
Table 37. Europe Molecular Diagnostics Infectious Disease Testing Market Size by Country (2025-2030) & (US$ Million)
Table 38. Asia-Pacific Molecular Diagnostics Infectious Disease Testing Market Size Growth Rate by Region (US$ Million): 2019 VS 2023 VS 2030
Table 39. Asia-Pacific Molecular Diagnostics Infectious Disease Testing Market Size by Region (2019-2024) & (US$ Million)
Table 40. Asia-Pacific Molecular Diagnostics Infectious Disease Testing Market Size by Region (2025-2030) & (US$ Million)
Table 41. Latin America Molecular Diagnostics Infectious Disease Testing Market Size Growth Rate by Country (US$ Million): 2019 VS 2023 VS 2030
Table 42. Latin America Molecular Diagnostics Infectious Disease Testing Market Size by Country (2019-2024) & (US$ Million)
Table 43. Latin America Molecular Diagnostics Infectious Disease Testing Market Size by Country (2025-2030) & (US$ Million)
Table 44. Middle East & Africa Molecular Diagnostics Infectious Disease Testing Market Size Growth Rate by Country (US$ Million): 2019 VS 2023 VS 2030
Table 45. Middle East & Africa Molecular Diagnostics Infectious Disease Testing Market Size by Country (2019-2024) & (US$ Million)
Table 46. Middle East & Africa Molecular Diagnostics Infectious Disease Testing Market Size by Country (2025-2030) & (US$ Million)
Table 47. Abbott Laboratories Company Detail
Table 48. Abbott Laboratories Business Overview
Table 49. Abbott Laboratories Molecular Diagnostics Infectious Disease Testing Product
Table 50. Abbott Laboratories Revenue in Molecular Diagnostics Infectious Disease Testing Business (2019-2024) & (US$ Million)
Table 51. Abbott Laboratories Recent Development
Table 52. BD Company Detail
Table 53. BD Business Overview
Table 54. BD Molecular Diagnostics Infectious Disease Testing Product
Table 55. BD Revenue in Molecular Diagnostics Infectious Disease Testing Business (2019-2024) & (US$ Million)
Table 56. BD Recent Development
Table 57. bioMérieux Company Detail
Table 58. bioMérieux Business Overview
Table 59. bioMérieux Molecular Diagnostics Infectious Disease Testing Product
Table 60. bioMérieux Revenue in Molecular Diagnostics Infectious Disease Testing Business (2019-2024) & (US$ Million)
Table 61. bioMérieux Recent Development
Table 62. Thermo Fisher Scientific Company Detail
Table 63. Thermo Fisher Scientific Business Overview
Table 64. Thermo Fisher Scientific Molecular Diagnostics Infectious Disease Testing Product
Table 65. Thermo Fisher Scientific Revenue in Molecular Diagnostics Infectious Disease Testing Business (2019-2024) & (US$ Million)
Table 66. Thermo Fisher Scientific Recent Development
Table 67. F. Hoffmann-La Roche Company Detail
Table 68. F. Hoffmann-La Roche Business Overview
Table 69. F. Hoffmann-La Roche Molecular Diagnostics Infectious Disease Testing Product
Table 70. F. Hoffmann-La Roche Revenue in Molecular Diagnostics Infectious Disease Testing Business (2019-2024) & (US$ Million)
Table 71. F. Hoffmann-La Roche Recent Development
Table 72. Siemens AG Company Detail
Table 73. Siemens AG Business Overview
Table 74. Siemens AG Molecular Diagnostics Infectious Disease Testing Product
Table 75. Siemens AG Revenue in Molecular Diagnostics Infectious Disease Testing Business (2019-2024) & (US$ Million)
Table 76. Siemens AG Recent Development
Table 77. Veridex Company Detail
Table 78. Veridex Business Overview
Table 79. Veridex Molecular Diagnostics Infectious Disease Testing Product
Table 80. Veridex Revenue in Molecular Diagnostics Infectious Disease Testing Business (2019-2024) & (US$ Million)
Table 81. Veridex Recent Development
Table 82. Luminex Company Detail
Table 83. Luminex Business Overview
Table 84. Luminex Molecular Diagnostics Infectious Disease Testing Product
Table 85. Luminex Revenue in Molecular Diagnostics Infectious Disease Testing Business (2019-2024) & (US$ Million)
Table 86. Luminex Recent Development
Table 87. GenMark Diagnostics Company Detail
Table 88. GenMark Diagnostics Business Overview
Table 89. GenMark Diagnostics Molecular Diagnostics Infectious Disease Testing Product
Table 90. GenMark Diagnostics Revenue in Molecular Diagnostics Infectious Disease Testing Business (2019-2024) & (US$ Million)
Table 91. GenMark Diagnostics Recent Development
Table 92. Qiagen NV Company Detail
Table 93. Qiagen NV Business Overview
Table 94. Qiagen NV Molecular Diagnostics Infectious Disease Testing Product
Table 95. Qiagen NV Revenue in Molecular Diagnostics Infectious Disease Testing Business (2019-2024) & (US$ Million)
Table 96. Qiagen NV Recent Development
Table 97. Genomix Biotech Company Detail
Table 98. Genomix Biotech Business Overview
Table 99. Genomix Biotech Molecular Diagnostics Infectious Disease Testing Product
Table 100. Genomix Biotech Revenue in Molecular Diagnostics Infectious Disease Testing Business (2019-2024) & (US$ Million)
Table 101. Genomix Biotech Recent Development
Table 102. BioTheranostics Company Detail
Table 103. BioTheranostics Business Overview
Table 104. BioTheranostics Molecular Diagnostics Infectious Disease Testing Product
Table 105. BioTheranostics Revenue in Molecular Diagnostics Infectious Disease Testing Business (2019-2024) & (US$ Million)
Table 106. BioTheranostics Recent Development
Table 107. GenMark Diagnostics Company Detail
Table 108. GenMark Diagnostics Business Overview
Table 109. GenMark Diagnostics Molecular Diagnostics Infectious Disease Testing Product
Table 110. GenMark Diagnostics Revenue in Molecular Diagnostics Infectious Disease Testing Business (2019-2024) & (US$ Million)
Table 111. GenMark Diagnostics Recent Development
Table 112. Research Programs/Design for This Report
Table 113. Key Data Information from Secondary Sources
Table 114. Key Data Information from Primary Sources
List of Figures
Figure 1. Global Molecular Diagnostics Infectious Disease Testing Market Size Comparison by Type (2024-2030) & (US$ Million)
Figure 2. Global Molecular Diagnostics Infectious Disease Testing Market Share by Type: 2023 VS 2030
Figure 3. Bacterial Infectious Disease Testing Features
Figure 4. Viral Infectious Disease Testing Features
Figure 5. Parasitic Infectious Disease Testing Features
Figure 6. Global Molecular Diagnostics Infectious Disease Testing Market Size Comparison by Application (2024-2030) & (US$ Million)
Figure 7. Global Molecular Diagnostics Infectious Disease Testing Market Share by Application: 2023 VS 2030
Figure 8. Hospital Case Studies
Figure 9. Laboratory Research Case Studies
Figure 10. Molecular Diagnostics Infectious Disease Testing Report Years Considered
Figure 11. Global Molecular Diagnostics Infectious Disease Testing Market Size (US$ Million), Year-over-Year: 2019-2030
Figure 12. Global Molecular Diagnostics Infectious Disease Testing Market Size, (US$ Million), 2019 VS 2023 VS 2030
Figure 13. Global Molecular Diagnostics Infectious Disease Testing Market Share by Region: 2023 VS 2030
Figure 14. Global Molecular Diagnostics Infectious Disease Testing Market Share by Players in 2023
Figure 15. Global Top Molecular Diagnostics Infectious Disease Testing Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Molecular Diagnostics Infectious Disease Testing as of 2023)
Figure 16. The Top 10 and 5 Players Market Share by Molecular Diagnostics Infectious Disease Testing Revenue in 2023
Figure 17. North America Molecular Diagnostics Infectious Disease Testing Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 18. North America Molecular Diagnostics Infectious Disease Testing Market Share by Country (2019-2030)
Figure 19. United States Molecular Diagnostics Infectious Disease Testing Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 20. Canada Molecular Diagnostics Infectious Disease Testing Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 21. Europe Molecular Diagnostics Infectious Disease Testing Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 22. Europe Molecular Diagnostics Infectious Disease Testing Market Share by Country (2019-2030)
Figure 23. Germany Molecular Diagnostics Infectious Disease Testing Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 24. France Molecular Diagnostics Infectious Disease Testing Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 25. U.K. Molecular Diagnostics Infectious Disease Testing Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 26. Italy Molecular Diagnostics Infectious Disease Testing Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 27. Russia Molecular Diagnostics Infectious Disease Testing Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 28. Nordic Countries Molecular Diagnostics Infectious Disease Testing Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 29. Asia-Pacific Molecular Diagnostics Infectious Disease Testing Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 30. Asia-Pacific Molecular Diagnostics Infectious Disease Testing Market Share by Region (2019-2030)
Figure 31. China Molecular Diagnostics Infectious Disease Testing Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 32. Japan Molecular Diagnostics Infectious Disease Testing Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 33. South Korea Molecular Diagnostics Infectious Disease Testing Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 34. Southeast Asia Molecular Diagnostics Infectious Disease Testing Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 35. India Molecular Diagnostics Infectious Disease Testing Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 36. Australia Molecular Diagnostics Infectious Disease Testing Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 37. Latin America Molecular Diagnostics Infectious Disease Testing Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 38. Latin America Molecular Diagnostics Infectious Disease Testing Market Share by Country (2019-2030)
Figure 39. Mexico Molecular Diagnostics Infectious Disease Testing Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 40. Brazil Molecular Diagnostics Infectious Disease Testing Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 41. Middle East & Africa Molecular Diagnostics Infectious Disease Testing Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 42. Middle East & Africa Molecular Diagnostics Infectious Disease Testing Market Share by Country (2019-2030)
Figure 43. Turkey Molecular Diagnostics Infectious Disease Testing Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 44. Saudi Arabia Molecular Diagnostics Infectious Disease Testing Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 45. Abbott Laboratories Revenue Growth Rate in Molecular Diagnostics Infectious Disease Testing Business (2019-2024)
Figure 46. BD Revenue Growth Rate in Molecular Diagnostics Infectious Disease Testing Business (2019-2024)
Figure 47. bioMérieux Revenue Growth Rate in Molecular Diagnostics Infectious Disease Testing Business (2019-2024)
Figure 48. Thermo Fisher Scientific Revenue Growth Rate in Molecular Diagnostics Infectious Disease Testing Business (2019-2024)
Figure 49. F. Hoffmann-La Roche Revenue Growth Rate in Molecular Diagnostics Infectious Disease Testing Business (2019-2024)
Figure 50. Siemens AG Revenue Growth Rate in Molecular Diagnostics Infectious Disease Testing Business (2019-2024)
Figure 51. Veridex Revenue Growth Rate in Molecular Diagnostics Infectious Disease Testing Business (2019-2024)
Figure 52. Luminex Revenue Growth Rate in Molecular Diagnostics Infectious Disease Testing Business (2019-2024)
Figure 53. GenMark Diagnostics Revenue Growth Rate in Molecular Diagnostics Infectious Disease Testing Business (2019-2024)
Figure 54. Qiagen NV Revenue Growth Rate in Molecular Diagnostics Infectious Disease Testing Business (2019-2024)
Figure 55. Genomix Biotech Revenue Growth Rate in Molecular Diagnostics Infectious Disease Testing Business (2019-2024)
Figure 56. BioTheranostics Revenue Growth Rate in Molecular Diagnostics Infectious Disease Testing Business (2019-2024)
Figure 57. GenMark Diagnostics Revenue Growth Rate in Molecular Diagnostics Infectious Disease Testing Business (2019-2024)
Figure 58. Bottom-up and Top-down Approaches for This Report
Figure 59. Data Triangulation
Figure 60. Key Executives Interviewed
Table 1. Global Molecular Diagnostics Infectious Disease Testing Market Size Growth Rate by Type (US$ Million): 2019 VS 2023 VS 2030
Table 2. Key Players of Bacterial Infectious Disease Testing
Table 3. Key Players of Viral Infectious Disease Testing
Table 4. Key Players of Parasitic Infectious Disease Testing
Table 5. Global Molecular Diagnostics Infectious Disease Testing Market Size Growth by Application (US$ Million): 2019 VS 2023 VS 2030
Table 6. Global Molecular Diagnostics Infectious Disease Testing Market Size by Region (US$ Million): 2019 VS 2023 VS 2030
Table 7. Global Molecular Diagnostics Infectious Disease Testing Market Size by Region (2019-2024) & (US$ Million)
Table 8. Global Molecular Diagnostics Infectious Disease Testing Market Share by Region (2019-2024)
Table 9. Global Molecular Diagnostics Infectious Disease Testing Forecasted Market Size by Region (2025-2030) & (US$ Million)
Table 10. Global Molecular Diagnostics Infectious Disease Testing Market Share by Region (2025-2030)
Table 11. Molecular Diagnostics Infectious Disease Testing Market Trends
Table 12. Molecular Diagnostics Infectious Disease Testing Market Drivers
Table 13. Molecular Diagnostics Infectious Disease Testing Market Challenges
Table 14. Molecular Diagnostics Infectious Disease Testing Market Restraints
Table 15. Global Molecular Diagnostics Infectious Disease Testing Revenue by Players (2019-2024) & (US$ Million)
Table 16. Global Molecular Diagnostics Infectious Disease Testing Market Share by Players (2019-2024)
Table 17. Global Top Molecular Diagnostics Infectious Disease Testing Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Molecular Diagnostics Infectious Disease Testing as of 2023)
Table 18. Ranking of Global Top Molecular Diagnostics Infectious Disease Testing Companies by Revenue (US$ Million) in 2023
Table 19. Global 5 Largest Players Market Share by Molecular Diagnostics Infectious Disease Testing Revenue (CR5 and HHI) & (2019-2024)
Table 20. Key Players Headquarters and Area Served
Table 21. Key Players Molecular Diagnostics Infectious Disease Testing Product Solution and Service
Table 22. Date of Enter into Molecular Diagnostics Infectious Disease Testing Market
Table 23. Mergers & Acquisitions, Expansion Plans
Table 24. Global Molecular Diagnostics Infectious Disease Testing Market Size by Type (2019-2024) & (US$ Million)
Table 25. Global Molecular Diagnostics Infectious Disease Testing Revenue Market Share by Type (2019-2024)
Table 26. Global Molecular Diagnostics Infectious Disease Testing Forecasted Market Size by Type (2025-2030) & (US$ Million)
Table 27. Global Molecular Diagnostics Infectious Disease Testing Revenue Market Share by Type (2025-2030)
Table 28. Global Molecular Diagnostics Infectious Disease Testing Market Size by Application (2019-2024) & (US$ Million)
Table 29. Global Molecular Diagnostics Infectious Disease Testing Revenue Market Share by Application (2019-2024)
Table 30. Global Molecular Diagnostics Infectious Disease Testing Forecasted Market Size by Application (2025-2030) & (US$ Million)
Table 31. Global Molecular Diagnostics Infectious Disease Testing Revenue Market Share by Application (2025-2030)
Table 32. North America Molecular Diagnostics Infectious Disease Testing Market Size Growth Rate by Country (US$ Million): 2019 VS 2023 VS 2030
Table 33. North America Molecular Diagnostics Infectious Disease Testing Market Size by Country (2019-2024) & (US$ Million)
Table 34. North America Molecular Diagnostics Infectious Disease Testing Market Size by Country (2025-2030) & (US$ Million)
Table 35. Europe Molecular Diagnostics Infectious Disease Testing Market Size Growth Rate by Country (US$ Million): 2019 VS 2023 VS 2030
Table 36. Europe Molecular Diagnostics Infectious Disease Testing Market Size by Country (2019-2024) & (US$ Million)
Table 37. Europe Molecular Diagnostics Infectious Disease Testing Market Size by Country (2025-2030) & (US$ Million)
Table 38. Asia-Pacific Molecular Diagnostics Infectious Disease Testing Market Size Growth Rate by Region (US$ Million): 2019 VS 2023 VS 2030
Table 39. Asia-Pacific Molecular Diagnostics Infectious Disease Testing Market Size by Region (2019-2024) & (US$ Million)
Table 40. Asia-Pacific Molecular Diagnostics Infectious Disease Testing Market Size by Region (2025-2030) & (US$ Million)
Table 41. Latin America Molecular Diagnostics Infectious Disease Testing Market Size Growth Rate by Country (US$ Million): 2019 VS 2023 VS 2030
Table 42. Latin America Molecular Diagnostics Infectious Disease Testing Market Size by Country (2019-2024) & (US$ Million)
Table 43. Latin America Molecular Diagnostics Infectious Disease Testing Market Size by Country (2025-2030) & (US$ Million)
Table 44. Middle East & Africa Molecular Diagnostics Infectious Disease Testing Market Size Growth Rate by Country (US$ Million): 2019 VS 2023 VS 2030
Table 45. Middle East & Africa Molecular Diagnostics Infectious Disease Testing Market Size by Country (2019-2024) & (US$ Million)
Table 46. Middle East & Africa Molecular Diagnostics Infectious Disease Testing Market Size by Country (2025-2030) & (US$ Million)
Table 47. Abbott Laboratories Company Detail
Table 48. Abbott Laboratories Business Overview
Table 49. Abbott Laboratories Molecular Diagnostics Infectious Disease Testing Product
Table 50. Abbott Laboratories Revenue in Molecular Diagnostics Infectious Disease Testing Business (2019-2024) & (US$ Million)
Table 51. Abbott Laboratories Recent Development
Table 52. BD Company Detail
Table 53. BD Business Overview
Table 54. BD Molecular Diagnostics Infectious Disease Testing Product
Table 55. BD Revenue in Molecular Diagnostics Infectious Disease Testing Business (2019-2024) & (US$ Million)
Table 56. BD Recent Development
Table 57. bioMérieux Company Detail
Table 58. bioMérieux Business Overview
Table 59. bioMérieux Molecular Diagnostics Infectious Disease Testing Product
Table 60. bioMérieux Revenue in Molecular Diagnostics Infectious Disease Testing Business (2019-2024) & (US$ Million)
Table 61. bioMérieux Recent Development
Table 62. Thermo Fisher Scientific Company Detail
Table 63. Thermo Fisher Scientific Business Overview
Table 64. Thermo Fisher Scientific Molecular Diagnostics Infectious Disease Testing Product
Table 65. Thermo Fisher Scientific Revenue in Molecular Diagnostics Infectious Disease Testing Business (2019-2024) & (US$ Million)
Table 66. Thermo Fisher Scientific Recent Development
Table 67. F. Hoffmann-La Roche Company Detail
Table 68. F. Hoffmann-La Roche Business Overview
Table 69. F. Hoffmann-La Roche Molecular Diagnostics Infectious Disease Testing Product
Table 70. F. Hoffmann-La Roche Revenue in Molecular Diagnostics Infectious Disease Testing Business (2019-2024) & (US$ Million)
Table 71. F. Hoffmann-La Roche Recent Development
Table 72. Siemens AG Company Detail
Table 73. Siemens AG Business Overview
Table 74. Siemens AG Molecular Diagnostics Infectious Disease Testing Product
Table 75. Siemens AG Revenue in Molecular Diagnostics Infectious Disease Testing Business (2019-2024) & (US$ Million)
Table 76. Siemens AG Recent Development
Table 77. Veridex Company Detail
Table 78. Veridex Business Overview
Table 79. Veridex Molecular Diagnostics Infectious Disease Testing Product
Table 80. Veridex Revenue in Molecular Diagnostics Infectious Disease Testing Business (2019-2024) & (US$ Million)
Table 81. Veridex Recent Development
Table 82. Luminex Company Detail
Table 83. Luminex Business Overview
Table 84. Luminex Molecular Diagnostics Infectious Disease Testing Product
Table 85. Luminex Revenue in Molecular Diagnostics Infectious Disease Testing Business (2019-2024) & (US$ Million)
Table 86. Luminex Recent Development
Table 87. GenMark Diagnostics Company Detail
Table 88. GenMark Diagnostics Business Overview
Table 89. GenMark Diagnostics Molecular Diagnostics Infectious Disease Testing Product
Table 90. GenMark Diagnostics Revenue in Molecular Diagnostics Infectious Disease Testing Business (2019-2024) & (US$ Million)
Table 91. GenMark Diagnostics Recent Development
Table 92. Qiagen NV Company Detail
Table 93. Qiagen NV Business Overview
Table 94. Qiagen NV Molecular Diagnostics Infectious Disease Testing Product
Table 95. Qiagen NV Revenue in Molecular Diagnostics Infectious Disease Testing Business (2019-2024) & (US$ Million)
Table 96. Qiagen NV Recent Development
Table 97. Genomix Biotech Company Detail
Table 98. Genomix Biotech Business Overview
Table 99. Genomix Biotech Molecular Diagnostics Infectious Disease Testing Product
Table 100. Genomix Biotech Revenue in Molecular Diagnostics Infectious Disease Testing Business (2019-2024) & (US$ Million)
Table 101. Genomix Biotech Recent Development
Table 102. BioTheranostics Company Detail
Table 103. BioTheranostics Business Overview
Table 104. BioTheranostics Molecular Diagnostics Infectious Disease Testing Product
Table 105. BioTheranostics Revenue in Molecular Diagnostics Infectious Disease Testing Business (2019-2024) & (US$ Million)
Table 106. BioTheranostics Recent Development
Table 107. GenMark Diagnostics Company Detail
Table 108. GenMark Diagnostics Business Overview
Table 109. GenMark Diagnostics Molecular Diagnostics Infectious Disease Testing Product
Table 110. GenMark Diagnostics Revenue in Molecular Diagnostics Infectious Disease Testing Business (2019-2024) & (US$ Million)
Table 111. GenMark Diagnostics Recent Development
Table 112. Research Programs/Design for This Report
Table 113. Key Data Information from Secondary Sources
Table 114. Key Data Information from Primary Sources
List of Figures
Figure 1. Global Molecular Diagnostics Infectious Disease Testing Market Size Comparison by Type (2024-2030) & (US$ Million)
Figure 2. Global Molecular Diagnostics Infectious Disease Testing Market Share by Type: 2023 VS 2030
Figure 3. Bacterial Infectious Disease Testing Features
Figure 4. Viral Infectious Disease Testing Features
Figure 5. Parasitic Infectious Disease Testing Features
Figure 6. Global Molecular Diagnostics Infectious Disease Testing Market Size Comparison by Application (2024-2030) & (US$ Million)
Figure 7. Global Molecular Diagnostics Infectious Disease Testing Market Share by Application: 2023 VS 2030
Figure 8. Hospital Case Studies
Figure 9. Laboratory Research Case Studies
Figure 10. Molecular Diagnostics Infectious Disease Testing Report Years Considered
Figure 11. Global Molecular Diagnostics Infectious Disease Testing Market Size (US$ Million), Year-over-Year: 2019-2030
Figure 12. Global Molecular Diagnostics Infectious Disease Testing Market Size, (US$ Million), 2019 VS 2023 VS 2030
Figure 13. Global Molecular Diagnostics Infectious Disease Testing Market Share by Region: 2023 VS 2030
Figure 14. Global Molecular Diagnostics Infectious Disease Testing Market Share by Players in 2023
Figure 15. Global Top Molecular Diagnostics Infectious Disease Testing Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Molecular Diagnostics Infectious Disease Testing as of 2023)
Figure 16. The Top 10 and 5 Players Market Share by Molecular Diagnostics Infectious Disease Testing Revenue in 2023
Figure 17. North America Molecular Diagnostics Infectious Disease Testing Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 18. North America Molecular Diagnostics Infectious Disease Testing Market Share by Country (2019-2030)
Figure 19. United States Molecular Diagnostics Infectious Disease Testing Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 20. Canada Molecular Diagnostics Infectious Disease Testing Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 21. Europe Molecular Diagnostics Infectious Disease Testing Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 22. Europe Molecular Diagnostics Infectious Disease Testing Market Share by Country (2019-2030)
Figure 23. Germany Molecular Diagnostics Infectious Disease Testing Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 24. France Molecular Diagnostics Infectious Disease Testing Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 25. U.K. Molecular Diagnostics Infectious Disease Testing Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 26. Italy Molecular Diagnostics Infectious Disease Testing Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 27. Russia Molecular Diagnostics Infectious Disease Testing Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 28. Nordic Countries Molecular Diagnostics Infectious Disease Testing Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 29. Asia-Pacific Molecular Diagnostics Infectious Disease Testing Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 30. Asia-Pacific Molecular Diagnostics Infectious Disease Testing Market Share by Region (2019-2030)
Figure 31. China Molecular Diagnostics Infectious Disease Testing Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 32. Japan Molecular Diagnostics Infectious Disease Testing Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 33. South Korea Molecular Diagnostics Infectious Disease Testing Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 34. Southeast Asia Molecular Diagnostics Infectious Disease Testing Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 35. India Molecular Diagnostics Infectious Disease Testing Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 36. Australia Molecular Diagnostics Infectious Disease Testing Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 37. Latin America Molecular Diagnostics Infectious Disease Testing Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 38. Latin America Molecular Diagnostics Infectious Disease Testing Market Share by Country (2019-2030)
Figure 39. Mexico Molecular Diagnostics Infectious Disease Testing Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 40. Brazil Molecular Diagnostics Infectious Disease Testing Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 41. Middle East & Africa Molecular Diagnostics Infectious Disease Testing Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 42. Middle East & Africa Molecular Diagnostics Infectious Disease Testing Market Share by Country (2019-2030)
Figure 43. Turkey Molecular Diagnostics Infectious Disease Testing Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 44. Saudi Arabia Molecular Diagnostics Infectious Disease Testing Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 45. Abbott Laboratories Revenue Growth Rate in Molecular Diagnostics Infectious Disease Testing Business (2019-2024)
Figure 46. BD Revenue Growth Rate in Molecular Diagnostics Infectious Disease Testing Business (2019-2024)
Figure 47. bioMérieux Revenue Growth Rate in Molecular Diagnostics Infectious Disease Testing Business (2019-2024)
Figure 48. Thermo Fisher Scientific Revenue Growth Rate in Molecular Diagnostics Infectious Disease Testing Business (2019-2024)
Figure 49. F. Hoffmann-La Roche Revenue Growth Rate in Molecular Diagnostics Infectious Disease Testing Business (2019-2024)
Figure 50. Siemens AG Revenue Growth Rate in Molecular Diagnostics Infectious Disease Testing Business (2019-2024)
Figure 51. Veridex Revenue Growth Rate in Molecular Diagnostics Infectious Disease Testing Business (2019-2024)
Figure 52. Luminex Revenue Growth Rate in Molecular Diagnostics Infectious Disease Testing Business (2019-2024)
Figure 53. GenMark Diagnostics Revenue Growth Rate in Molecular Diagnostics Infectious Disease Testing Business (2019-2024)
Figure 54. Qiagen NV Revenue Growth Rate in Molecular Diagnostics Infectious Disease Testing Business (2019-2024)
Figure 55. Genomix Biotech Revenue Growth Rate in Molecular Diagnostics Infectious Disease Testing Business (2019-2024)
Figure 56. BioTheranostics Revenue Growth Rate in Molecular Diagnostics Infectious Disease Testing Business (2019-2024)
Figure 57. GenMark Diagnostics Revenue Growth Rate in Molecular Diagnostics Infectious Disease Testing Business (2019-2024)
Figure 58. Bottom-up and Top-down Approaches for This Report
Figure 59. Data Triangulation
Figure 60. Key Executives Interviewed
Our team would be happy to assist you with your queries.
About us
Accurate data, The latest market trends, And deeper research directions.
Our sole purpose is to provide a basis for leaders in all walks of life to make more appropriate decisions, to help companies solve existing problems and achieve business goals
Latest reports
Camelina Seeds - Global Market Share and Ranking, Overall Sales and Demand Forecast 2024-2030
Sep 11, 24
Bentgrass Seeds - Global Market Share and Ranking, Overall Sales and Demand Forecast 2024-2030
Sep 11, 24
Barley Seeds - Global Market Share and Ranking, Overall Sales and Demand Forecast 2024-2030
Sep 11, 24
Useful links
Our Contacts
Room 2306, T6 Fuxing World Financial Center, Kaifu District, Changsha, Hunan, China
(+86) 159 1069 5232